Lot numbers appear on both individual vials and the Bravelle box, and begin with alpha numeric codes such as L1, K1 or H1.

1

The packaging and/or vials.

Proof of purchase between March 2014 and October 2015.

2

Any documented evidence of your out-of-pocket expenses, such as receipts or bank statements that may highlight the drug.

Any documents concerning your treatments / procedures.

3

Any documents concerning your fertility treatments and medical procedures for which Bravelle was prescribed, including all documents evidencing your out-of-pocket expenses.

About The Allergan Biocell Textured Breast Implants Case:

This lawsuit comes in the wake of the FDA's request that Allergan issue a recall of its Biocell textured breast implants and tissue expanders. Allergan agreed and is removing these products from the global market. The FDA requested the recall based on newly submitted Medical Device Reports reporting worldwide cases of BIA-ALCL and BIA-ALCL-related deaths associated with these implants.

*Required Fields

This is attorney advertising. Past results cannot be an assurance of future success in any given case, because each matter must be decided on its own merits.



Click Here to Read the Class Action Complaint

To speak with us on a confidential basis about your Allergan Biocell implants, or to learn how you can join the class action, please complete the contact form below. Your consultation with our law firm will be free of charge.

Join the class action against Nano-X:

The typical things needed to move forward:

aabramowitz@bm.net

(215) 875-3015 

bergermontague.com

Berger Montague
1818 Market Street, Suite 3600
Philadelphia, PA 19103

Andrew Abramowitz, Esq. 

Counsel Information:

Copyright 2020 Berger Montague
1818 Market Street, Suite 3600, 

Philadelphia, PA 19103
(800) 424-6690
| info@bm.net

Legal Representation Information for Anyone Who Purchased Nano-X Imaging Ltd. Securities Between August 21, 2020 and September 15, 2020.

Berger Montague has filed a nationwide class action lawsuit against medical device manufacturer Allergan to protect women from the harmful Biocell Textured Breast Implant. The case is Alabama Doe, et al. v. Allergan, Inc., et al.

On July 24, 2019, Allergan announced a recall of certain Biocell textured breast implants after reports showed a possible link between the implants and a type of non-Hodgkin's lymphoma (cancer of the immune system).

Our class action claims the recall doesn't fully compensate proposed class members for the costs of replacing or retaining their implants and aims to force Allergan to pay for the costs of surgery, diagnostic testing, and medical monitoring in people who have Biocell implants.

Double-click to edit this text